Yesterday, Aug. 25, 2015, 114 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $558.60 to $2,694,280.00.

Highlighted Stocks Traded by Insiders:

US Physical Therapy (USPH) - FREE Research Report

Mcafee Lawrance W, who is Chief Financial Officer at US Physical Therapy, sold 2,000 shares at $47.06 on Aug. 25, 2015. Following this transaction, the Chief Financial Officer owned 46,852 shares meaning that the stake was reduced by 4.09% with the 2,000-share transaction.

Chapman Harry S, who is Director at US Physical Therapy, bought 1,000 shares at $46.90 on Aug. 25, 2015. Following this transaction, the Director owned 33,750 shares meaning that the stake was boosted by 3.05% with the 1,000-share transaction.

The shares most recently traded at $46.42, down $0.48, or 1.03% since the insider transaction. Historical insider transactions for US Physical Therapy go as follows:

  • 4-Week # shares bought: 250
  • 4-Week # shares sold: 14,598
  • 12-Week # shares bought: 250
  • 12-Week # shares sold: 14,598
  • 24-Week # shares bought: 250
  • 24-Week # shares sold: 50,897

The average volume for US Physical Therapy has been 65,200 shares per day over the past 30 days. US Physical Therapy has a market cap of $573.4 million and is part of the health care sector and health services industry. Shares are up 10.18% year-to-date as of the close of trading on Tuesday.

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics in the United States. The stock currently has a dividend yield of 1.3%. The company has a P/E ratio of 27.3. Currently, there are 3 analysts who rate US Physical Therapy a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on USPH - FREE

TheStreet Quant Ratings rates US Physical Therapy as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and reasonable valuation levels. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full US Physical Therapy Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

National Health Investors (NHI) - FREE Research Report

Jobe James R, who is Director at National Health Investors, bought 100 shares at $56.68 on Aug. 25, 2015. Following this transaction, the Director owned 4,425 shares meaning that the stake was boosted by 2.31% with the 100-share transaction.

Mendelsohn D. Eric, who is Interim CEO and President at National Health Investors, bought 750 shares at $56.99 on Aug. 25, 2015. Following this transaction, the Interim CEO and President owned 4,250 shares meaning that the stake was boosted by 21.43% with the 750-share transaction.

The shares most recently traded at $55.26, down $1.73, or 3.13% since the insider transaction. Historical insider transactions for National Health Investors go as follows:

  • 4-Week # shares bought: 5,600
  • 4-Week # shares sold: 5,950
  • 12-Week # shares bought: 6,100
  • 12-Week # shares sold: 5,950
  • 24-Week # shares bought: 8,065
  • 24-Week # shares sold: 5,950

The average volume for National Health Investors has been 221,300 shares per day over the past 30 days. National Health Investors has a market cap of $2.1 billion and is part of the financial sector and real estate industry. Shares are down 21.58% year-to-date as of the close of trading on Tuesday.

National Health Investors Inc. is a real estate investment trust. It invests in the real estate markets of United States. The firm invests in the health care properties primarily in the long-term care and senior housing industries. The stock currently has a dividend yield of 6.09%. The company has a P/E ratio of 17.6. Currently, there is 1 analyst who rates National Health Investors a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NHI - FREE

TheStreet Quant Ratings rates National Health Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, good cash flow from operations, expanding profit margins and increase in net income. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full National Health Investors Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

AmeriServ Financial (ASRV) - FREE Research Report

Wise Robert L, who is Director at AmeriServ Financial, bought 547 shares at $3.33 on Aug. 25, 2015. Following this transaction, the Director owned 121,945 shares meaning that the stake was boosted by 0.45% with the 547-share transaction.

The shares most recently traded at $3.23, down $0.10, or 2.97% since the insider transaction. Historical insider transactions for AmeriServ Financial go as follows:

  • 4-Week # shares bought: 209
  • 12-Week # shares bought: 413
  • 24-Week # shares bought: 4,817

The average volume for AmeriServ Financial has been 44,900 shares per day over the past 30 days. AmeriServ Financial has a market cap of $61.3 million and is part of the financial sector and banking industry. Shares are up 3.52% year-to-date as of the close of trading on Tuesday.

AmeriServ Financial, Inc operates as the bank holding company for AmeriServ Financial Bank that provides various consumer, mortgage, and commercial financial products. The stock currently has a dividend yield of 1.23%. The company has a P/E ratio of 17.1.

Exclusive Offer: Get the latest Stock Analysis on ASRV - FREE

TheStreet Quant Ratings rates AmeriServ Financial as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and a generally disappointing performance in the stock itself. Get the full AmeriServ Financial Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.